Sitc 2025 Ak132. Working at SITC Container Lines Malaysia Sdn Bhd Company Profile (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the acceptance of two abstracts for poster presentations at the upcoming Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting taking. And it's worth remembering Shattuck Labs, whose own take on CD47 differs by the inclusion of a CD40L domain to activate macrophages; further data from early trials of SL-154 are due this year.
SITC fleet expansion gets underway from www.linerlytica.com
The Women in Cancer Immunotherapy Network (WIN) is a SITC initiative seeking to promote and elevate women in the cancer immunotherapy field SITC 2025 is held in Washington DC, United States, from 11/5/2025 to 11/5/2025 in Gaylord National Resort and Convention Center.
SITC fleet expansion gets underway
SITC 2025 is held in Washington DC, United States, from 11/5/2025 to 11/5/2025 in Gaylord National Resort and Convention Center. 8, 2024 /PRNewswire/ -- At the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024), held in Houston, USA, from November 6 - 10, Akeso Biopharma (9926.HK) presented the mechanism of action (MOA) research findings of its innovative bispecific antibody, AK132, targeting both Claudin18.2 (CLDN18.2) and CD47. The 2025 SITC Spring Scientific, Cellular Therapy for Solid Tumors, will address the recent advances in adoptive cellular therapy for solid tumors and rate-limiting challenges that impede bringing these novel therapies to patients in need.
Home SITC 2025. 8, 2024 /PRNewswire/ -- At the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024), held in Houston, USA, from November 6 - 10, Akeso Biopharma (9926.HK) presented the mechanism of action (MOA) research findings of its innovative bispecific antibody, AK132, targeting both Claudin18.2 (CLDN18.2) and CD47. The Women in Cancer Immunotherapy Network (WIN) is a SITC initiative seeking to promote and elevate women in the cancer immunotherapy field
Home SITC 2025. SITC 2025 is held in Washington DC, United States, from 11/5/2025 to 11/5/2025 in Gaylord National Resort and Convention Center. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the acceptance of two abstracts for poster presentations at the upcoming Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting taking.